江蘇吳中(600200.SH):第一期員工持股計劃完成非交易過户
格隆匯3月15日丨江蘇吳中(600200.SH)公佈,2022年3月15日,公司收到中國證券登記結算有限責任公司出具的《過户登記確認書》,公司回購專用證券賬户所持有的370.50萬股已於2022年3月14日非交易過户至公司第一期員工持股計劃賬户,過户價格為3.68元/股。截至公吿披露日,公司第一期員工持股計劃賬户持有公司股份370.50萬股,佔公司總股本的0.52%。至此,公司第一期員工持股計劃已全部完成股票非交易過户。
根據《江蘇吳中醫藥發展股份有限公司第一期員工持股計劃》的規定,公司本次員工持股計劃的鎖定期分別為12個月、24個月、36個月,自公司公吿最後一筆標的股票過户至本次員工持股計劃名下之日(2022年3月14日)起計算,解鎖比例分別為40%、30%、30%,鎖定期滿後依據2022年-2024年度業績考核結果分期解鎖分配至持有人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.